Pipelines & Platforms
▪ Protein degrader for Prostate Cancer ▪ Protein degrader for Androgenetic Alopecia ▪ Non-covalent KRAS inhibitor for G12C, G12D, G13D, G12V mutations ▪ Protein degrader discovery platform open for research collaboration
Business Interests
Out-Licensing, Collaborative R&D
Contact Info
Wendy Lin
Operations Mgr
+886-921-233-794
anhorn01@anhornmed.com